For nearly 20 years, CutisPharma's singular focus has been to address the needs of patients who are unable to take capsules or tablets, such as children and the elderly, for whom no therapy is commercially available.
Mr. Palladino joined CutisPharma in May 2017 as Chief Financial Officer. Mr. Palladino is a Senior Executive with 35 years of global strategic and operating experience across multiple disciplines within the life sciences industry, including drug discovery, medical devices, and pharmaceuticals.
Mr. Palladino has served as CFO for 480 Biomedical, Claritas Genomics, BioNevia, CORRONA, PatientsLikeMe and Biosphere Medical. Mr. Palladino has also founded Oxus Medical (Oximetry in Cardiac Resynchronization) and Tesa Medical (Orthopedics). Mr. Palladino earned his MBA in Finance and Entrepreneurship from Babson College, Wellesley, MA.